{
    "clinical_study": {
        "@rank": "77087", 
        "arm_group": [
            {
                "arm_group_label": "Sufentanil NanoTab 20 mcg", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Sufentanil NanoTab 30 mcg", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo NanoTab", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a dose-finding study to determine if the sublingual administration of the Sufentanil\n      NanoTab is safe and effective in the treatment of post-operative pain."
        }, 
        "brief_title": "Safety and Efficacy of Sufentanil NanoTab for Management of Acute Pain Following Bunionectomy", 
        "completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "condition": "Acute Pain", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients scheduled for bunion surgery\n\n        Exclusion Criteria:\n\n          -  daily opioid use\n\n          -  drug or alcohol abuse\n\n          -  pregnant or breastfeeding women"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "101", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01710345", 
            "org_study_id": "SAP202"
        }, 
        "intervention": {
            "arm_group_label": [
                "Sufentanil NanoTab 20 mcg", 
                "Sufentanil NanoTab 30 mcg"
            ], 
            "intervention_name": "Sublingual sufentanil", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Sufentanil"
        }, 
        "is_fda_regulated": "Yes", 
        "lastchanged_date": "October 4, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Pasadena", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Lotus Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah"
                    }, 
                    "name": "Jean Brown Research"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Time Weighted Summed Pain Intensity Difference"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01710345"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "AcelRx Pharmaceuticals, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AcelRx Pharmaceuticals, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}